Register
Quizzes
eMediQuiz
eMediNexus, 22-05-2019
#Cardiology
           


In patients with stable cardiovascular disease at very high risk for CVD events (expected 10-year event rate of greater than 25 percent), such as those in the proposed NCEP guidelines, start high-intensity statin therapy plus a rather than targeting a goal LDL-C.
  •    PCSK9-ab
  •    Ezetimibe
  •    Fenofibrate
  •    Plasmapheresis